CURRICULUM VITAE
ROBERT W. PETERS
Professor of Medicine
Division of Cardiology
Department of Medicine
University of Maryland
Chief, Cardiology Section
Baltimore VA Medical Center
Baltimore, Maryland 21201
Office Location – 4D129A, VA Medical Center
Phone: # 410 605 7191
Fax: # 410 605 7934
E-mail: robert.peters2@va.gov
EDUCATION and TRAINING:
1959 - 1963
Columbia University, New York City: B.A.
1963 - 1967
Chicago Medical School, Chicago, IL: M.D.
1967 - 1968
University of Southern California, Los Angeles County
General Hospital (Internship), Los Angeles, CA
1968 - 1969
Michael Reese Hospital (Residency), Chicago, IL
1971 - 1972
George Washington University Hospital (Residency),
Washington, DC
1972 - 1974
University of California San Francisco, Mount Zion
Hospital (Cardiology Fellowship) San Francisco, CA
CERTIFICATION:
1973
American Board of Internal Medicine
1975
American Board of Internal Medicine Cardiovascular
Subspecialty Exam
LICENSURE:
MILITARY SERVICE:
California (inactive); Maryland
1969 - 1970
U.S. Army Medical Corps Viet Nam
1970 - 1971
Walter Reed Army Hospital
FACULTY POSITIONS:
1992
Professor of Medicine, University of Maryland School of
Medicine
1988 - Present
Chief, Cardiology Section Baltimore VA Medical Center
1979 - 1992
Associate Professor of Medicine, University of Maryland
School of Medicine
1992 - Present
Professor of Medicine, University of Maryland School of
Medicine
1979 - 1995
Director, Coronary Care Unit, Baltimore VA Medical
Center
1977 - 1979
Assistant Professor of Medicine in Residence, University of
California, San Francisco, Division of Cardiology
1976 - 1979
Director, Coronary Care Unit, San Francisco General
Hospital
1975 - 1976
Acting Director, Coronary Care Unit, San Francisco
General Hospital
1974 - 1975
Program Project Officer, National Medical Association
Audiovisual Grant for Production of Self-Instructional
Packets on Acute Myocardial Infarction
1974 - 1976
Instructor of Medicine, University of California, San
Francisco Division of California
COMMITTEES:
1972 - 1974
Pharmacy and Therapeutics Committee Mt. Zion Hospital
1975 - 1979
Critical Care Committee San Francisco General Hospital
1975 - 1979
CCU Discharge Planning Committee San Francisco
General Hospital
1977 - 1979
Research Committee San Francisco General Hospital
1979 - 1983
Mortality Classification Committee Beta Blocker Heart
Attack Trial (NHBLI)
1979 - 1981
Chairperson, CPR Committee Baltimore VA Medical
Center
1981 - 1993
Chairperson, Critical Care Committee Baltimore VA
Medical Center
1985 - Present
Chairperson, Human Research Subcommittee Baltimore
VA Medical Center
1981 - 1994
CCU Committee Baltimore VA Medical Center
1987 - 1994
Publications and Ancillary Studies Committee, Cardiac
Arrhythmia Suppression Trial (CAST)
1979 - 1981
Chairperson, CPR Committee Baltimore VA Medical
Center
1983 - 1986
Research and Development Committee Baltimore VA
Medical Center
1983 - 1991
Pharmacy and Therapeutics Committee Baltimore VA
Medical Center
1985 - 1990
Smoking Committee Baltimore VA Medical Center
1980 - 1992
Human Volunteers Research Committee University of
Maryland School of Medicine (Institutional Review Board)
1986 - 1989
Research Committee, Maryland Affiliate of American
Heart Association
1987 - Present
Member, VA Cardiology Field Advisory Group (National)
1993 - 1995
Member, Intravenous Cordarone Mortality Committee
(Wyeth-Ayerst Research)
1998 - 1999
2001-present
2002-present
Member, Clinical Endpoints Adjudication Committee
ELITE II Trial (Merck)
Member, Advisory Group for the Centers for Medicare and
Medicare Services (CMS)
Cardiology Consultant, Geriatric Research Educational Clinical
Center, Department of Gerontology, University of Maryland
2004-present
Member, Advisory Committee, The Claude D Pepper Center,
Geriatric Research Educational Clinical Center, University of
Maryland
2007-present
Member, Circulatory System Devices Advisory Panel, U. S.
Food and Drug Administration
TEACHING RESPONSIBILITIES
Cardiology Blue Team Attending - VA Medical Center
Electrophysiology Service Attending - VA Medical Center
4 months
52 weeks
HONORS and AWARDS:
1965
Pharmacology Research Prize Chicago Medical School
1970
Bronze Star U.S. Army Medical Corps
1981
Honorary Alpha Omega Alpha Society Chicago Medical School
1982
Visiting Professor of Medicine Mt. Zion Hospital and Medical Center San
Francisco, California
CONTRACTS and GRANTS
1979
Principal Investigator, Beta Blocker Heart Attack Trial (NHLBI)
1979
Regional Advisory Groups (RAGS) VA
1981
Coinvestigator, Persantine and Aspirin Reinfarction Study (Part II)
1986
Principal Investigator, Cardiac Arrhythmia Suppression Trial (NHLBI)
1989
Principal Investigator, Recainam Arrhythmia Suppression Trial (WyethAyerst Research)
1998 Principal Investigator, The Prophylaxis of Medical Patients for
Thromboembolism (PROMPT) Pilot Study (VA Cooperative Study)
2002 Principal Investigator, Triggers of Ventricular Arrhythmias (TOVA) NHLBI
2002 Principal Investigator, A Simplified System for Internal Cardioversion of
Atrial Fibrillation
PRESENTATIONS:
1. Cooperative prospective study of bundle branch block.. American Heart Association
meetings, November, 1975. Anaheim, California.
2. Clinical implications of prospective studies of bundle branch block. Recent Advances
in Internal Medicine. University of California, San Francisco, California. April, 1976.
3. Panel on antiarrhythmic drugs. Recent Advances in Internal Medicine. University of
California, San Francisco, California. April, 1976.
4. Clinical applications of intracardiac electrogram. Academy for the Advancement of
Medical Instrumentation meeting. San Francisco, California. March, 1977.
5. Management of patients with AV or bundle branch block. American Medical
Association meetings. San Francisco, California. June, 1977.
6. Prophylactic permanent pacemakers for patients with chronic bundle branch block.
American College of Cardiology. Anaheim, California. March 6-9, 1978.
7. The pre-hospital phase of acute myocardial infarction. American College of
Physicians. San Francisco, California. March, 1979.
8. Serial studies of infranodal conduction in patients with bundle branch block.
American Heart Association meetings. Dallas, Texas. November, 1978.
9. Site and pattern of progressive atrioventricular block in patients with bundle branch
block: A long-term collaborative study. American Heart Association meetings.
Anaheim, California. November, 1979.
10. Serial electrophysiologic studies in patients with bundle branch block. American
Heart Association Meetings. Dallas, Texas. November, 1981.
11. Graded influence of the H-V interval on the incidence of spontaneous infranodal
block. American Heart Association Meetings. Dallas, Texas. November, 1981
12. Effects of acute changes in ventricular volume and pressure of AV conduction.
American College of Cardiology Meetings. Atlanta, Georgia. April, 1982.
13. Permanent prophylactic cardiac pacing for patients with bundle branch block and
syncope. American Heart Association Meetings. Dallas, Texas. November, 1982.
14. Electrophysiologic evaluation of patients with bundle branch block. American Heart
Association Meetings. Dallas, Texas. November, 1982.
15. Electrophysiologic effects of cigarette smoking in man. American Heart Association
Annual Scientific Session. Anaheim, California. November, 1983.
16. Longterm Management of paroxysmal tachycardia by burst overdrive pacing.
American College of Cardiology Meetings. Dallas, Texas. March, 1984.
17. Prognostic value of QTC prolongation: The BHAT experience. American Heart
Association Annual Scientific Session. Miami Beach, Florida. November 1984.
18. Propranolol and the circadian variation in frequency of sudden cardiac death: The
BHAT Experience. American Heart Association Annual Scientific Session. Anaheim,
California, 1987.
19. Circadian Variation in sudden cardiac death in the Beta Blocker Heart Attack Trial,
International Council on Circadian Variation, Boston, Massachusetts, Feb 1988.
20. Circadian Pattern of sudden arrhythmic death in the Cardiac Arrhythmia Suppression
Trial, International Council on Circadian Variation, Palm Beach, Florida., May, 1990.
21. Circadian Variation of sudden arrhythmic death in patients receiving encainide or
flecainide in the Cardiac Arrhythmia Suppression Trial. American Heart Association
Annual Scientific Session, Dallas, Texas, November 1990.
22. Relationship of onset of acute myocardial infarction to time of awakening: The
CAST experience, International Council on Circadian Variation, Key Largo, Florida,
April 1991.
23. Overdrive Atrial Pacing for Management of Atrial Flutter World Congress of
Cardiology/North American Society for Pacing and Electrophysiology Washington, D.C.,
May, 1991.
24. Relationship of onset of acute myocardial infarction to the time of awakening: The
CAST Experience. American Heart Association Annual Scientific Session, Anaheim,
California 1991.
25. Treatment of ventricular arrhythmias in the 1990's. 10th Annual Advances in
Cardiology. San Francisco, California December 1992.
26. Uses and limitations of the implantable defibrillator. 10th Annual Advances in
Cardiology. San Francisco, California December 1992.
27. Increased onset of acute myocardial infarction on Monday. American Heart
Association Annual Scientific Session Atlanta, Georgia. November 1993.
28. Smoking Cessation and arrhythmic death. American Heart Association. Annual
Scientific Session. Atlanta, Georgia, November, 1993.
29. Morning Peak in ventricular arrhythmias detected by time of implantable
defibrillator therapy. American College of Cardiology Annual Scientific Sesssion;
New Orleans, Louisiana, March 1995.
30. Seasonal variation in implantable cardioverter defibrillator therapy. American
College of Cardiology Annual scientific Session; Anaheim, CA, March 2000.
INVITED ARTICLES:
1. Hirschfeld D, Peters RW, Abbott JA, Kunkle F, and Scheinman MM: The sick sinus
and ailing atrium. Western Journal of Medicine, 12:473, December, 1974.
2. Peters RW: Differential diagnosis of chest pain. Emergency Medical Service 4:33,
November-December, 1975.
3. Hart R, Peters RW, Rubinstein M, O'Young J, Thomas A and Scheinman MM: A
review of instrumentation and therapeutic techniques in the diagnosis and management of
patients with supraventricular tachycardia. Medical Instrumentation 12:268-273, 1978.
4. Peters RW, Scheinman MM: Emergency management of supraventricular tachycardia.
Medical Clinics of North America 63:73-92, 1979.
5. Scheinman MM, Goldschlager N, Peters RW: Bundle branch block. Cardiovascular
clinics 11:57-81, 1980.
6. Peters RW: Treatment of supraventricular tachycardia. Recenti Progressi on
Medicina 71:48-68, 1981.
7. Peters RW: Emergency: Paroxysmal supraventricular tachycardia. Hospital
Medicine 18(4):68c-68o, 1982.
8. Somelofski C and Peters RW: Antiarrhythmic drugs: The issue of compliance. Annals
of the N.Y. Academy of Sciences 432:286-295, 1984.
9. Peters RW: Permanent cardiac pacing for complete heart block complicating acute
anterior myocardial infarction. Proceedings in International Symposium on Progress in
Clinical Pacing 1984.
10. Peters RW: Temporary transcutaneous pacing: New indications for an old technique.
Journal of the Association of Operating Room Nurses 44:245-249, 1986.
11. Peters RW: Beta blockers and mortality following myocardial infarction: More
questions than answers (editorial). Archives Internal Medicine 147:33, 1987.
12. Peters RW: Indication for pacing in acute myocardial infarction. Cardio 4:59, 1987.
13. Peters RW: Arrhythmias and chest pain. Chest pain and Cardiovascular Diagnosis
3:1987.
14. Peters RW, Fisher ML: Combined use of procainamide and beta blockers in the
management of ventricular arrhythmias. Arrhythmia Clinics 4:10, 1987.
15. Tomasseli G, Peters RW, Guarnieri T: The automatic implantable cardioverter
defibrillator in clinical practice. Is it effective and when should it be used? Choices in
Cardiology. 2:121, 1988.
16. Peters RW: Propranolol and the morning increase in sudden cardiac death (the BHAT
Experience) American Journal of Cardiology 66:57-59, 1990.
17. Peters RW: Circadian rhythms and sudden cardiac death: Pathophysiologic insight
gained from clinical trials. Current Concepts in Arrhythmia Management (Summer: 916, 1991).
18. Peters, RW, Gold MR: Arrhythmias developing after coronary artery bypass surgery.
Cardio. Nov. 1992:31-40.
19. Peters, RW, Fisher ML: Clinical questions: When are ventricular extrasystoles
important? Choices in Cardiology 7:237,1993 .
20. Peters, RW, Fisher ML: Clinical questions: Use of amiodarone. Choices in
Cardiology 8:57-60, 1994
21. Peters,RW: Circadian incidence of arrhythmias and sudden cardiac death.
Cardiovascular circadian rhythms 1994;5:1-8.
22. Peters RW, Brooks MM: Does smoking cessation cause a reduction in arrhythmic
death? Cardiology Review 1996;13:11-14.
23. Peters RW: Circadian patterns and triggers of sudden cardiac death. Cardiology
Clinics 1996;14:185-194.
24. Peters RW, Mergner W, Ghiorzi T, Benitez RM. A 70 year old man with atrial
fibrillation and stroke. Maryland Medical Journal March/April 1999:74-79.
25. Peters RW. Heart block and conduction disturbances. In Current Treatment Options
in Cardiovascular Disease (Ed. Francis GS) Current Science Inc. Philadelphia
1999;1:153-165.
26. Gold MR, Peters, RW. Permanent pacemakers in patients with dilated
cardiomyopathy. Cardiac Electrophysiology Review 1999;2:381-383..
27. Peters RW, Gold MR. Pacing for patients with congestive heart failure and dilated
cardiomyopathy. Cardiovascular Clinics of North America 2000;18:55-66.
28. Peters RW, Gold MR. Implantable cardioverter defibrillators. Med Clin North Amer
2001;85:343-365.
29. Peters RW, Gold MR. Are there seasonal variations in the incidence of sudden
cardiac death and life-threatening arrhythmias? J Critical Illness 2001;16:358-359..
31. Gold MR Peters RW. How much is the arrhythmic risk for heart failure patients and
does resynchronization therapy modify it? Proceedings of the 7th International
Workshop on Cardiac Arrhythmias, Venice 2001.
32. Peters RW, Gold MR. The influence of gender on arrhythmias. Cardiol Rev
2004;12:97-105.
33. Peters RW, Gold MR. Editorial: Chronobiology of arrhythmias: interesting curiosity
or important clue to pathophysiology? J Cardiovasc Electrophysiol 2002;10:1015-16.
34. Peters RW. Editorial: Obstructive sleep apnea and cardiovascular disease. CHEST
2005;127:1-3
35. Peters RW. How strong is the evidence that the treatment of obstructive sleep apnea
syndrome improves outcomes in patients with obstructive sleep apnea? The Journal
of Respiratory Diseases 2005;26:283.
36. Peters RW. Clinical Consultation: Reducing cardiovascular risks in patients with
obstructive sleep apnea. The Journal of Respiratory Diseases (Supplement) July, 2006:6.
37. Anand RG, Peters RW, Donahue TP. Obesity and dysrhythmias. Journal of
Cardiometabolism. (In Press).
REFEREED ARTICLES
1. Scheinman MM, Kunkle F, Peters RW, Hirschfeld D, Schoenfeld P, Abbott JA, Modin
G: Atrial pacing in patients with sinus node dysfunction. American Journal on
Medicine, 61:641, November, 1976.
2. Peters RW, Rubinstein M, and Scheinman MM: Precise "on-line" measurements of
intracardiac electrograms. Journal of Electrocardiography, 9:329, 1976.
3. Peters RW, Scheinman MM: Effects of intravenous carnitive in patients with
ventricular arrhythmias. Cardiovascular Medicine, 2:701, 1977.
4. Scheinman MM, Peters RW, Mies C and Modin G: Prognostic value of infranodal
conduction time in patients with chronic bundle branch block. Circulation 56:240-245,
1977.
5. Peters RW, Norman A, Parmley W, Emilson B, Scheinman MM, Cheitlin M: Effect of
methylprednisone on myocardial infarct size in man. Chest 73:483-488, 1978.
6. Peters RW, Shafton E, Frank S, Thomas A, and Scheinman MM: Uses and limitations
of radio frequency-triggered pacemakers. A long-term follow-up study. Annals of
Internal Medicine, 88:17-22, 1978.
7. Scheinman MM, Strauss HC, Abbott J, Peters, RW, Benditt DG, Evans GT, Wallace
AG: Clinical and electrophysiologic evaluation of patients with sinus pauses and exit
block. European Journal of Cardiology 8:41-60, 1978.
8. Massie B, Scheinman MM, Peters RW, Desai JM, Hirschfeld D, O'Young J: Clinical
and electrophysiologic findings on patients with paroxysmal slowing of the sinus rate and
apparent Mobitz type II AV block. Circulation 58:305-314, 1978.
9. Desai JM, Scheinman MM, Peters RW, and O'Young J: Electrophysiologic effects of
disopyramide in patients with bundle branch block. Circulation 59:215-225, 1979.
10. Peters RW, Scheinman MM, Modin G, O'Young J, Somelofski CA, Mies C.:
Permanent prophylactic pacing in patients with chronic bundle branch block. American
Journal of Medicine 66:978-985, 1979.
11. Peters RW, Scheinman M, Raskin S, Desai J: Determination of His-Purkinje
refractoriness in man by means of His bundle pacing. Circulation 60:956-959.
12. Scheinman MM, Remedios P, Cheitlin M, Peters RW, Holford M, Desai J, Abbott J:
Effects of antiarrhythmic drugs on atrioventricular conduction in patients with acute
myocardial infarction. Circulation 62:20-28, 1980.
13. Peters RW, Scheinman MM, Raskin S, Thomas AN: Unusual complications of
epicardial pacemakers. American Journal of Cardiology 45:1088-1094, 1980
14. Desai J, Scheinman MM, Hirschfeld D, Gonzalez R, Peters RW: Cardiovascular
collapse associated with disopyramide therapy. Chest 79:545-551, 1981.
15. Gonzales R, Scheinman MM, Desai J, Kersh E, Peters RW: Enhanced atrioventricular
nodal conduction in a patient with dual extranodal pathways. Journal of
Electrocardiology 13(1), 85-92, 1980.
16. Peters RW, Scheinman MM, Gonzalez RP: Atrial and ventricular vulnerability in a
patient with Wolff-Parkinson-White Syndrome. Pace 4:17-22, 1980.
17. Peters RW, Wohl BA, Fisher ML, Carliner NH, Plotnick GD: Nonoperative removal
of a tined-tipped endocardial pacemaker catheter. Pace 5:129-132, 1982.
18. Wohl BA, Peters RW, Carliner NH, Plotnick GD, Fisher ML: Late unheralded
pacemaker pocket infection due to staphylococcus epidermidis: A new clinical entity.
Pace 5:190-195, 1982.
19. Gonzalez R, Scheinman M, Thomas A, Desai J, Peters RW, Dzinzio B:
Electrophysiologic characterization of surgically induced HIS bundle rhythm in man.
Pace 5:152-162, 1981.
20. Peters RW, Scheinman MM, Dhingra R, Rosen K, McAnulty J, Rahimtoola S, Modin
G: Serial electrophysiologic studies in patients with chronic bundle branch block.
Circulation 65:1480-1485, 1982.
21. Scheinman MM, Peters RW, Sauve MJ, Desai J, Abbott JA, Cogan J, Wohl B,
William K: The value of the HQ interval in patients with bundle branch block and the
role of prophylactic permanent pacing. American Journal of Cardiology 50:1316-1322,
1982.
22. Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propranolol
in patients with acute myocardial infarction. I. Mortality results. Journal of the
American Medical Association 247:1707, 1982.
23. Plotnick GD, Fisher ML, Lerner B, Carliner NH, Peters RW, Becker L: Collateral
circulation in unstable angina. Chest 82:719-725, 1982.
24. Fisher ML, Carliner NH, Becker LC, Peters RW, Plotnick GD: Serum creatine
kinase in the diagnosis of acute myocardial infarction: Optimal frequency sampling.
JAMA 249:393-394, 1983.
25. Peters RW, Resnick S, Fisher ML, Carliner NH, Plotnick GD, Scheinman MM:
Acute changes in infranodal conduction time following left ventriculography and
sublingual nitroglycerin administration in man. American Heart Journal 106:464-70,
1983.
26. Peters RW, Alikhan M, Morady F, Carliner NH, Scheinman MM: Unusual features
of bypass conduction in Wolff-Parkinson-White syndrome and atrial fibrillation.
American Journal of Cardiology 52:1357-1359, 1983.
27. Peters RW, Hamilton BP, Hamilton J, Kuzbida G, Pavlis R: Mechanism of
arrhythmias following abrupt clonidine withdrawal. Clinical Pharmacology and
Therapeutics 34:435-439, 1983.
28. Kushner M, Magiros E, Peters RW, Carliner NH, Plotnick GD, Fisher ML: The
electrophysiologic effects of oral cibenzoline. Journal of Electrocardiology 17:15-24,
1984.
29. Hall-Craggs M, Light P, Peters RW: Immune complex nephritis developing during
treatment with the calcium-blocking agent nifedipine - A case report. Human Pathology
15:691-694, 1984.
30. Scheinman MM, Peters RW, Morady F, Sauve MJ, Malone P, Modin S;
Electrophysiologic studies in patients with bundle branch block. Pace 6:1157-1165,
1983.
31. Fisher ML, Kelemen MH, Collins D, Holder L, Winzeberg G, Plotnick GD, Morris F,
Moran G, Carliner NH, Peters RW, Strauss HW: Technetium-99m pyrophosphate infarct
avid scintigraphy: Limitations in the diagnosis of patients with suspected acute
myocardial infarction. American Heart Journal 110:347-353, 1985.
32. Peters RW, Nussbaum S, Mailhot J, Lief LH, Paley HW: Catheter-induced A-V nodal
block occurring during electrophysiologic study, Pace 7:248-251, 1984.
33. Peters RW, Scheinman MM, Morady F, Jacobson L: Long-term management of
recurrent tachycardia by cardiac burst pacing. Pace 8:35-44, 1985.
34. Peters RW, Kushner M, Knapp K: Giant pacemaker spikes: An electrocardiographic
artifact. Chest 87:256-257, 1985.
35. Weber L, Nashel DJ, Peters RW: Persistent chest pain due to sternal wire sutures: A
complication of coronary artery bypass surgery. Southern Medical Journal 78:10181019, 1985.
36. Morady F, Higgins J, Peters RW, Schwartz AB, Shen EN, Bhandari A, Scheinman
MM, Sauve MJ: Electrophysiologic testing on bundle branch block and unexplained
syncope. American Journal of Cardiology 54:587-591, 1984.
37. Ochitill HN, Havassy B, Byrd RC, Peters RW: Leaving a cardiology service against
medical advice. J. Chronic Dis 38:79-84, 1985.
38. Carliner NH, Fisher ML, Plotnick GD, Garbart H, Rapport A, Kelemen MH, Moran
GW, Gadacz T, Peters RW: Routine preoperative exercise testing in patients undergoing
major non-cardiac surgery. American Journal of Cardiology 56:51-58, 1985.
39. Kmetzo, JJ, Peters RW, Plotnick GD, Carliner NH, Baumgartner WA, Fisher ML:
Left atrial mass: Thrombus mimicking myxoma. Chest 88:906-907, 1986.
40. Berliner D, Okun M, Peters RW, Carliner NH, Plotnick GD, Fisher ML:
Transcutaneous temporary pacing in the operating room. JAMA 254:84-86, 1985.
41. Fisher ML, Plotnick GD, Peters RW, Carliner NH: Beta-blockers in congestive
cardiomyopathy: Conceptual advance or contraindication? American Journal of
Medicine 80 (suppl 2B):59-66, 1986.
42. Weber L, Peters RW: Delayed chest wall complications of median sternotomy.
Southern Medical Journal 79:723-727, 1986.
43. Kushner M, Peters RW: Prolonged sinus arrest complicating a thrombotic stroke.
Pace 9:248-249, 1986.
44. Persantine-Aspirin Reinfarction Study Group: Persantine-aspirin reinfarction study
part II: Secondary coronary prevention with persantine and aspirin. JACC 7:251-269,
1986.
45. Carliner NH, Fisher ML, Plotnick GD, Moran GW, Kelemen MH, Gadacz TR, Peters
RW: The preoperative electrocardiogram as an indicator of risk in major noncardiac
surgery. Canadian Journal of Cardiology 2:134-137, 1986.
46. Peters RW, Byington R, Arensberg D, Friedman LM, Romhilt DW, Barker A,
Laubach C, Wilmer G, Goldstein S: Mortality in beta blocker heart attack trial: The
circumstances surrounding death. J Chronic Dis 40:75-82, 1987.
47. Schamp DJ, Carliner NH, Peters RW: Pindolol therapy for bradycardia/tachycardia
syndrome. Canadian Journal of Cardiology 3:212, 1987.
48. Celano C, Peters RW, Fisher ML: Coronary collateral blood flow in a patient with
angiographically normal coronary arteries. Catheterization and Cardiovascular Diagnosis
13:325, 1987.
49. Peters RW, Benowitz NL, Valenti S, Modin G, Fisher ML: The electrophysiologic
effects of cigarette smoking in patients with and without chronic beta blocker therapy.
American Journal of Cardiology 60:1078, 1987.
50. Panos R, Sutton F, Young-Hyman P, Peters RW: Sudden Death Associated with
Alcohol Ingestion. Pace 11:1988.
51. Peters RW, Hamilton B, Hamilton J: The Incidence of Chronic Arrhythmias
Associated With Mild Hypocalcemia induced by low-dose diuretic therapy in
hypertensive Southern Medical Journal. 82:966, 1989.
52. Peters RW, Muller JE, Goldstein S, Byington R, Friedman L. Propranolol and the
Morning Increase in the Frequency of Sudden Cardiac Death (BHAT Study) American
Journal of Cardiology. 63:1518, 1989.
53. The Cardiac Arrhythmia-Suppression Trial (CAST) Investigators. Preliminary report:
Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia
suppression after myocardial infarction. New England Journal Medicine 1989; 321:406412.
54. Jafri SM, Tilley BC, Peters RW, Schultz LR, Goldstein S. Effects of cigarette
smoking and propranolol in survivors of acute myocardial infarction American Journal of
Cardiology. 217:271-276, 1990.
55. Peters RW, Byington RP, Barker A, Yusuf S. Prognostic valve of prolonged
ventricular repolarization following myocardial infarction: The BHAT experience. J
Clin Epidem 43:167-172, 1990.
56. Peters RW, Propranolol and the morning increase in sudden cardiac death (the
BHAT Experience) American Journal of Cardiology 66:57-59, 1990.
57. Echt DS, Liebson PR, Mitchell JB, Peters RW, Obias-Manno D, Barker AH,
Arensberg D, Baker A, Friedman L, Greene L, Hunther M, Richardson D and the CAST
Investigators. Mortality and Morbidity in patients randomized to receive encainide,
flecainide or placebo in the Cardiac Arrhythmia Suppression Trial. New Eng J Med
324:781-788, 1991.
58. Gillis AM, Peters Rw, Mitchell LB, Duff HJ, McDonald M, Wyse DG. Effects of left
ventricular dysfunction on the circadian variation of ventricular premature depolarization.
American Journal of Cardiology 69:1009-1014, 1992.
59. Peters RW, Buser GA, Kim HJ, Gold MR. Tricyclic overdose causing sustained
monomorphic ventricular tachycardia American Journal of Cardiology 70: 1226-1228,
1992.
60. Peters, RW, Kim HJ, Buser GA, Gold MR. Ischemically-medicated sustained
monomorphic ventricular tachycardia. Chest 104:1613-1614, 1993.
61. Peters, RW, Zoble RG, Liebson PR, Powitan Y, Brooks MM, Proschan M;
Identification of a secondary peak in myocardial infarction onset 11-12 hours after
awakening: The CAST experience J Am Coll Cardiol 22:998-1003,1993.
62. Peters RW, Mitchell LB, Brooks MM, Echt DS, Barker AH, Capone R, Liebson PR,
Greene LH for the CAST Investigators. Circadian Pattern of arrhythmic death in patients
receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression
Trial. J AM Coll Cardiol 23:293-289, 1994.
63. Gottlieb SS, Riggio D, Lauria S, Peters, RW, Shorofsky SR, Cines M, Froman D,
Gold MR. High dose oral amiodarone loading exerts important hemodynamic actions in
patients with congestive heart failure. J Am Coll Cardiol 23:560-564;1994.
64. Peters, RW, Foster, AH; Shorofsky, SR; Nolan, DA; Gold, MR: Spurions discharges
due to late insulation break in endocardial sensing lead for cardiovertor defibrillators,
PACE 18:478-481,1995.
65. Peters, RW; Weiss, DN; Carliner, NH; Feliciano, Z Shorofsky, SR; Gold, MR:
Overdrive pacing for atrial flutter. American Journal of Cardiology. 1994;74:1021-1023.
66. Riggio DW, Peters, RW, Feliciano Z, Gottlieb SS, Shorofsky SR, Gold MR,. Acute
electrophysiologic effects of amiodarone in patients with congestive heart failure. Am J.
Cardiol 1995;75:1158-1161.
67. Greenberg HM, Dwyer Jr. EM, Hochman JS, Steinberg JS, Echt DS, Peters RW:
Interaction of ischemia and encainide/flecainide treatment: a proposed mechanism for the
increased mortality in CAST I. British Heart Journal 1995;74:631-635.
68. Peters RW, Brooks MM, Todd L, Liebson PR, Wilhelmsen L: Smoking cessation and
arrhythmic death: the CAST experience. J Am Coll Cardiol 1995;26:1287-1292.
69. Foster MT, Peters RW, Froman D, Shorofsky SR, Gold MR: Electrophysiologic
effects and predictors of success of combination therapy with class Ia and Ib
antiarrhythmic drugs for sustained ventricular arrhythmias. Am J Cardiol 1996;78:47-50.
70. Tummala RV, Riggio DR, Peters RW, Shorofsky SR, Gold MR: Chronic rise in
defibrillation threshold with a hybrid lead system. Am J Cardiol 1996;78:309-312.
71. Peters RW, McQuillan S, Resnick SK, Gold MR: Increased Monday incidence of
life-threatening ventricular arrhythmias: experience with a third generation implantable
defbrillator. Circulation 1996;94:1346-1349.
72. Goldstein S, Zoble RG, Akiyama T, Cohen JD, Lancaster S, Liebson PR, Rapaport
E, Goldberg AD, Peters RW, Gillis AM: The Relationship of Circadian Ventricular
Ectopy To Cardiac Mortality. Am J Cardiol 1996;78:881-885.
73. Weiss DN, Gold MR, Peters RW: Rate-responsive pacing mimicking ventricular
tachycardia. J Invas Cardiol 1996;8:228-230.
74. Peters RW, Brooks MM, Zoble RG, Liebson PR, Seals AA. Chronobiology of acute
myocardial infarction (CAST experience). Am J Cardiol 1996;78:1198-1201.
75. Kirk MM, Shorofsky SR, Khalighi K, Kavesh NG, Peters RW, Gold MR. Chronic
rise of monophasic defibrillation thresholds with a transvenous lead system. Am J
Cardiol 1997; 79:502-505.
76. Khalighi K, Florin TJ, Peters RW, Shorofsky SR, Gold MR. Distortion of intracardiac
electrograms following defibrillator shocks for atrial tachyarrhythmias. PACE 1997
20:1682-1685.
77. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with
pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and
submuscular approaches. J Am Coll Cardiol 1996; 28:1278-82.
78. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications associated with
pectoral implantation of cardioverter-defibrillators. PACE 1997; 20:208-211 .
79. Khalighi K, Daly B, Leino EV, Shorofsky SR, Kavesh NG,Peters RW, Gold MR.
Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 1997;
79:150-153.
80. Peters RW, Kavesh N, Pelini M, Gold MR. Permanent pacing from the coronary
sinus in a patient with an implantable defibrillator PACE 1997; 20:2286-2287.
81. Florin TJ, Weiss DN, Peters RW, Shorofsky SR, Gold MR. Induction of atrial
fibrillation with low energy shocks in patients with implantable cardioverter
defibrillators. Am J Cardiol 1997; 80:960-962.
82. Khalighi K, Peters RW, Feliciano Z, Shorofsky SR, Gold MR. Comparison of class I
and class III antiarrhythmic drugs for the suppression of sustained ventricular tachycardia
associated with coronary artery disease. Am J Cardiol 1997; 80:591-594.
83. Gold MR, Olsovsky MR, Pelini MA, Peters RW, Shorofsky SR. Comparison of
single- and dual-coil active pectoral defibrillation lead systems. J Am Coll Cardiol 1998;
31:1391-4.
84. Gold MR, Khalighi K, Kavesh NG, Daly B, Peters RW, Shorofsky SR. Clinical
predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 1997; 79:16231627.
85. Peters RW, Gilbert TB, Johns-Walton S, Gold MR. Lidocaine-related increase in
defibrillation threshold. Anesth Analg 1997; 85:299-300.
86. Weiss DN, Shorofsky SR, Peters RW, Gold MR. The effect of delivered energy on
defibrillation shock impedance. J Interventional Cardiac Electrophysiol 1998; 2:273-277.
87. Peters RW, Shorofsky SR, Pelini M, Olsovsky M, Gold MR. Overdrive atrial pacing
for conversion of atrial flutter: comparison of postoperative with non-postoperative
patients. Am Heart J 1999;137:100-103.
88. Peters RW, Gold MR. Reversible prolonged pacemaker failure due to electrocautery.
J Interventional Cardiac Electrophysiol 1998;2:343-344.
89. Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks
from implanted cardioverter defibrillators caused by sensing of diaphragmatic potentials.
J Interventional Cardiac Electrophysiol 1998;2:367-370.
90. Gold MR, Froman D, Kavesh NG, Peters RW, Foster AH, Shorofsky SR. A
comparison of pectoral and abdominal transvenous defibrillator implantation: analysis of
costs and outcomes. J Interventional Cardiac Electrophysiol 1998;2:345-349.
91. Kavesh NG, Olsovsky MR, Freudenberger RS, Conte JV, Peters RW, Shorofsky SR,
Gold MR. Intravenous amiodarone suppression of electrical storm refractory to chronic
oral amiodarone PACE 1999;22:665-667.
92. Cooklin M, Tummala RV, Peters RW, Shorofsky SR, Gold MR. Comparison of
bipolar and integrated sensing for redetection of ventricular fibrillation. Am Heart J
1999;138:133-6.
93. Peters RW, McQuillan S, Gold MR. Interaction of septadian and circadian rhythms in
life-threatening ventricular arrhythmias in patients with implantable cardioverter
defibrillators. Am J Cardiol 1999;84:555-557.
94. Degeratu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure
in implantable defibrillators: a comparison of two commonly used leads. J Cardiovasc
Electrophysiol 2000;11:21-24.
95. Gold MR, Brockman R, Peters RW, Olsovsky MR, Shorofsky SR. Acute
hemodynamic effects of right ventricular pacing site and pacing mode in patients with
congestive heart failure. Am J Cardiol 2000;85:1106-1109..
96. Pelini M, Peters RW, Khalighi K, Shorofsky SR, Gold MR. Short term escape rhythm
characteristics after radiofrequency ablation of the atrioventricular junction. J
Interventional Cardiac Electrophysiol 2000;4:301-305.
97. Ahrensfeld D, Balke CW, Benitez RM, Peters RW. Transient sinus node dysfunction
in acute myocardial infarction associated with the use of a coronary stent. Catheterization
and Cardiovascular Interventions 2000;50:349-351.
98. Peters RW, Zhang X, Gold MR. Clinical predictors and efficacy of antitachycardia
pacing in patients with implantable cardioverter defibrillators: the importance of the
patient’s sex. PACE 2001;24:70-74.
99. Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk MM, Peters RW, Gold MR. Temporal
decline in defibrillation thresholds with an active pectoral lead system. J Am Coll Cardiol
2001;38:1150-5.
100. Rashba EJ, Bouhouch R, Koshy S, MacMurdy K, Shorofsky SR, Peters RW, Gold
MR. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body
weight. Am J Cardiol 2001;88:1043-1045.
101.Peters RW, Zoble RG, Brooks MM. The onset of acute myocardial infarction during
sleep. Clin Cardiol 2002;25:237-241.
102. Rashba EJ, Cooklin M, MacMurdy K, Kavesh N, Kirk M, Sarang S, Peters RW,
Shorofsky SR, Gold MR. Effects of selective autonomic blockade on T-wave alternans.
Circulation 2002;105:837-842.
103. Rashba EJ, Bouhouch R, MacMurdy KA, Shorofsky SR, Peters RW, Gold MR.
Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J
2002;143:541-5.
104. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang s, Peters RW, Shorofsky
SR, Gold MR. Exercise is superior to pacing for T wave alternans measurement in
subjects with chronic coronary artery disease and left ventricular dysfunction. J
Cardiovasc Electrophysiol 2002;13:845-850.
105. Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky
SR, Gold MR. Influence of QRS duration on the prognostic value of T wave alternans. J
Cardiovasc Electrophysiol 2002;13:770-5.
106. Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on
defibrillation thresholds with a hybrid patch-coil lead system. J Interv Card
Electrophysiol 2003;9:391-6..
107. Rashba EJ, Bonner M, Wilson J, Shorofsky SR, Peters RW, Gold MR. Distal right
ventricular coil position reduces defibrillation thresholds. J Cardiovasc Electrophysiol
2003;14:1036-40.
108. Shorofsky SR, Peters RW, Rashba EJ, Gold MR: Comparison of step-down and
binary-search algorithms for determination of defibrillation threshold in humans. PACE
2004;27:218-20.
109. Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Optimization of atrial
defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol
2004;15:790-4.
110. Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. A new
protocol for transthoracic cardioversion of atrial fibrillation with a biphasic truncated
exponential shock waveform. AM J Cardiol 2004;94:1572-1574.
111. Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang SE, Peters RW, Shorofsky
SR, Gold MR. Enhanced detection of arrhythmia vulnerability using T wave alternans,
left ventricular ejection fraction, and programmed ventricular stimulation: a propective
study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol
2004;15:170-76.
112. Rashba EJ, Shorofsky SR, Brown T, Peters RW, Gold MR. Clinical predictors of
atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm
2005; 2:49-54.
113. Page RL, Zipes DP, Powell RM, Gold MR, Peters RW, Russo AM, Bigger JT, Sung
RJ, McBurnie MA. Seasonal variation in mortality in the Antiarrhythmic drugs versus
Implantable defibrillators Study registry. Heart Rhythm 2004;1:435-440.
114. Rashba EJ, Farasat M, Kirk MM, Shorofsky SR, Peters RW, Gold MR. Effect of an
active abdominal pulse generator on defibrillation thresholds with a dual coil,
transvenous ICD system. J Cardiovasc Electrophysiol 2006;17:617-620.
115. Lederle FA, Sacks JM, Fiore L, Landenfeld CS, Steinberg N, Peters RW, Eid AE,
Sebastian J, Stasek JE, Fye CL. The prophylaxis of medical patients for
Thromboembolism Pilot Study. Amer J Medicine 2006;119:54-59.
116. Rashba EJ, Shorofsky SR, Scheiner A, Conville R, Peters RW, Ma C, Gold MR.
Coronary sinus electrode does not reduce defibrillation thresholds. Heart Rhythm
2006;3:647-652.
117. Khan E, Voudoris A, Shorofsky SR, Peters RW. Inappropriate ICD discharges due
to “triple counting” during normal sinus rhythm. Journal Interventional Cardiac
Electrophysiology 2006;17:153-155.
118. Dickfeld T, Lei P, Jeudy J, Dong J, Voudouris A, Peters R Saba M, Shekhar R,
Shorofsky S. Integration of three-dimensional scar maps for ventricular tachycardia
ablation with positron emission tomography-computed tomography. JACC Imaging 2008
(in Press).
ABSTRACTS:
1. Scheinman MM, Kunkle FW, Peters RW, Schoenfeld PL, and Abbott JA: Sinoatrial
function and atrial refractoriness in patients with the sick sinus syndrome. Circulation,
48:1973.
2. Peters RW, Paley H, Chamorro G, Mailhot J, and Modin G: Effect of heart rate on
Myocardial contractility in man. Circulation 50: (Suppl III) 240, 1974.
3. Scheinman MM, Brennan M, Peters RW, and Hirschfeld DS: Cooperative prospective
study of patients with intraventricular conduction delay (short term results). Circulation,
50 (Suppl III), 1974.
4. Peters RW, Scheinman MM, and Shafton E: Long-term follow-up of patients with
radio frequency-triggered atrial pacemakers. Circulation 52: (Suppl III) 2244, 1974.
5. Hirschfeld DS, Peters RW, Kunkle F, and Scheinman MM: Sino-atrial conduction
time and abnormal perionodal refractoriness in patients with sinus node disease.
Circulation 52:(Suppl II) 231, 1976.
6. Scheinman MM, Brennan M, Modin G, and Peters RW: Cooperative prospective study
of bundle branch block. Circulation 52 (Suppl II) 113, 1975.
7. Scheinman MM, Evans GT, Abbott J, Peters RW, Wallace AG, Strauss HC:
Electrophysiologic testing of patients with sino-atrial block and sinus pauses. Circulation
53054: (Suppl II) 231, 1976.
8. Peters RW, Scheinman MM, and Rubinstein M: Clinical applications of the
intracardiac electrogram. AAMI, Abstract of Proceedings, 1976.
9. Peters RW, Scheinman MM, Hart R, Rubinstein M: Newer techniques in the
management of patients with intractable supraventricular tachycardia (SVT). AAMI,
Abstracts of Proceedings, 1976.
10. Rubinstein M, Peters RW, O'Young J, Scheinman MM: Instrumentation for
intracardiac electrophysiology. AMI, Abstracts of Proceedings, 1976.
11. Massie B, O'Young J, Peters RW, Hirschfeld D, Scheinman MM: Simultaneous sinus
slowing and type II atrioventricular block: A manifestation of hypervagotonia.
Circulation 55-56: (Suppl III) 154, 1977.
12. Peters RW, Scheinman MM, Modin G, O'Young, Somelifski CA, Mies C: Permanent
prophylactic pacing in patients with chronic bundle branch block. American Journal of
Cardiology 41:385, 1978.
13. Abbott JA, Feld, O'Young J, Peters RW, Desai J, Scheinman MM, Cheitlin M:
Electrocardiographic recognition of acute myocardial infarction. American Federation of
Clinical Research, 1978.
14. Abbott JA, Scheinman MM, Sheard C, O'Young J, Desai J, Peters RW, Strauss HC,
Modin G: Prognostic indicators of in patients with sinus node dysfunction. American
Federation of Clinical Research, 1978.
15. Massie B, O'Young J, Scheinman MM, Strauss H, Peters RW, Desai J: The
significance of autonomic blockade in the evaluation of sinus node dysfunction.
American Journal of Cardiology 41:433, 1978.
16. Scheinman MM, Peters RW, et al: Prognostic value of infranodal conduction time in
patients with chronic bundle branch block. Cardiology Digest, 1978.
17. Peters RW, McAnulty J, Scheinman M, Murphy E, Somieldfski C, Rahimtoola S:
Serial studies of intranatal conduction in patients with bundle branch block. Circulation
58: (Suppl II) 606, 1978.
18. Desai J, Hirscfeld D, Peters RW, Scheinman M, Gonzalez R: Electromechanical
dissociation associated with disopyramide. Circulation 58: (Suppl II) 190, 1978.
19. Massie B, O'Young J, Scheinman M, Strauss H, Desai J, Peters RW: Pharmacologic
challenge in the testing of patients with sinus node dysfunction. Clin Res 26(2):251A
20. Peters RW, Scheinman M, Dhingra R, Rosen K, McAnulty J, Rahimtoola S: Site and
pattern of progressive atrioventricular block in patients with bundle branch block: A
long-term collaboration study. Circulation 60: (suppl II) 190, 1979.
21. Scheinman M, Desai J, Gonzalez R, Peters RW, Thomas A, Dzindzio B: The effects
of Lidocaine on His bundle automaticity and rhythm in man. Circulation 58: (Suppl II)
29, 1978.
22. Fisher ML, Collins D, Kelemen M, Morris F, Carliner NH, Peters RW, Moran G,
Plotnick GD: Serum enzymes in diagnosis of acute myocardial infarction: Cost
effectiveness. American Federation of Clinical Research 28:294A, 1980.
23. Plotnick GD, Peters RW, Fisher ML: Arrhythmias in "Variant Angina". Clinical
Research 28:202A, 1980.
24. Peters RW, Abbott J, Desai J, Frais M, Scheinman M: Natural history of bundle
branch block effects of prophylactic pacemaker insertion. Proceedings of European
Congress of Cardiology. Paris, France, June 22-26, 1980.
25. Somelofski CA, Peters RW: Role of a nurse clinical trial. Proceedings of European
Congress of Cardiology. Paris, France, June 22-26, 1990.
26. Resnick S, Peters RW, Fisher ML, Plotnick GD, Carliner NH, Moran G: Effect of
changes in left ventricular volume upon infranodal conduction in man. Clinical Research
28:617A, 1980.
27. Peters RW, et al: Prophylactic permanent pacemakers for patients with chronic
bundle block. Medilex Digest Cardiology. August, 1980, pages 69-70.
28. Hanlon I, Scheinman MM, Desai J, Hess D, Gonzalez R, Peters RW, Budge R:
Mechanisms of ventricular tachycardia termination by vagal maneuvers. Proceedings of
European Congress of Cardiology. Paris, France, June 22-26, 1980.
29. Plotnick GD, Learner B, Carliner NH, Fisher ML, Peters RW, Becker L: Are
collaterals uncommon in patients with unstable angina? Clinical Research 28:202A, 980.
30. Fisher ML, Collins D, Kelemen M, Morris F, Carliner NH, Peters RW, Moran G,
Plotnick GD, Serum enzymes in diagnosis of acute myocardial infarction: Cost
effectiveness. Clinical Research 28:294A, 1980.
31. Wohl B, Peters RW, Fisher ML, Carliner NH, Plotnick GD: Late unheralded
pacemaker pocket infections due to staphylococcus epidermidas: A clinical entity.
Clinical Research 29:661A, 1981.
32. Fisher ML, Plotnick GD, Hamilton BP, Peters RW, Carliner NH, Mersey JH:
Intrinsic symptomimetic activity of pindolol: Evidence for interaction with pretreatment
symptomimetic tone. Clinical Research 9:650A, 1981.
33. Peters RW, Scheinman MM, Dhingra R, Rosen K, McAnulty J, Rahimtoola S: Serial
electrophysiologic studies in patients with bundle branch block. Circulation 64: (Suppl
IV) 144, 1981.
34. Scheinman MM, Peters RW, Sauve MJ, Desai J, Cogan J, Wohl B: Graded influence
of the H-V interval on the incidence of spontaneous infranodal block. Circulation 64:
(Suppl IV) 144, 1981.
35. Scheinman MM, Peters RW, Sauve MJ, Desai J, Abbott J: Prognosis of patients with
bundle branch block: Role of prophylactic pacing. International symposium on
Cardiology Electrophysiology, page 55, Ferrara, April-May, 1981.
36. Peters RW, Fisher ML, Resnick S, Plotnick GD, Carliner NH, Scheinman MM:
Effects of acute changes in ventricular volume and pressure on A-V conduction.
American Journal of Cardiology, 49:982, 1982.
37. Fisher ML, Plotnick GD, Hamilton JH, Hamilton BP, Peters RW, Carliner NH,
Mersey JH: Intrinsic sympathomimetic activity of pindolol: Evidence for interaction
with pretreatment sympathetic tone. American Journal of Cardiology, 49:924, 1982.
38. Peters RW, Scheinman MM, Sauve MJ, Desai J, Williams K, Cogan J, Wohl B:
Permanent prophylactic cardiac pacing for patients with bundle branch block. American
Journal of Cardiology, 49:952, 1982.
39. Higgins J, Scheinman M, Morady F, Hess D, Peters RW: Electrophysiologic
evaluation of patients with bundle branch block and syncope. Circulation 66: (Suppl II)
147, 1982.
40. Peters RW, Hamilton BP, Hamilton JH, Levinson PD, Kuzbida G, Pavlis R: The
incidence of arrhythmias following abrupt clonidine withdrawal. Clinical Research
30:693A, 1982.
41. Moran GW, Carliner NH, Fisher ML, Rapport A, Kelemen M, Peters RW, Gadacz T,
Plotnick GD: Should exercise testing be performed routinely before major noncardiac
surgery? Clinical Research 30L676A, 1982.
42. Magiros E, Kushner M, Peters RW, Carliner NH, Fisher ML, Plotnick GD:
Electrophysiology of oral cibenzoline. Clinical Research 30:693A, 1982
43. Peters RW, Valenti S, Benowitz N, Plotnick GD, Carliner NH, Charache S, Fisher
ML, Plotnick GD: Electrophysiologic Effects of Cigarette Smoking in Man. Circulation
68: (Suppl III) 421, 1983.
44. Davis RJ, MacLaren D, Peters RW: Possible interaction between cortisporin otic
suspension and warfarin. Annals of the American Society of Hospital Pharmacists, 1983.
45. Peters RW, Scheinman MM, Morady F, Jacobson L: Long-term management of
paroxysmal tachycardia by burst overdrive pacing. Journal of the American College of
Cardiology, 3 (2):473, 1984.
46. Carliner NH, Fisher ML, Rapport A, Kelemen M, Moran G, Peters RW, Gadacz T,
Plotnick GD: Preoperative exercise testing: Stratification of risk for major non-cardiac
surgery. Journal of the American College of Cardiology 1 (2):638, 1983.
47. Whipps RG, Carliner NH, Peters RW, Plotnick GD, Lesko L, Fisher ML: Nifedipine:
Time course of serum concentrations and hemodynamic changes during chronic oral
therapy. Clinical Research 32:248A, 1984.
48. Peters RW: Barker A, Byington R: Prognostic value of QTc prolongation: The
BHAT experience. Circulation 70:6, 1984.
49. Peters RW: Permanent cardiac pacing for complete heart block complicating acute
anterior myocardial infarctions. Cardiostimolazione 2:196, 1984.
50. Kostis JB, Byington RP, Goldstein S, Peters RW, Murphy ML: Mortality predictors
in survivors of myocardial infarction. The BHAT placebo group. JACC 1986.
51. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM: Propranolol and the
circadian variation in frequency of sudden cardiac death. Circulation 76: (Supp IV) 364,
1987.
52. Benowitz NL, Peters RW: Modin G: Benefit of propranolol in the Beta Blocker
Heart Attack trial is primarily in cigarette smokers. Clinical Pharmacal Ther 43:162,
1988.
53. Peters RW, Mitchell LB, Pawitan Y, Barker AH, Capone RJ, Echt DS: Circadian
pattern of Sudden Arrhythmic death in patients receiving encainide or flecainide in the
Cardiac Arrhythmia Suppression Trial. Circulation 82:546 1990.
54. Gillis AM, Peters RW: Mitchell LB, Duff HJ, McDonald M. Wyse DG: Circadian
Variation of Ventricular Arrhythmias: role of left ventricular function. JACC 17:222A,
1991.
55. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH,
Arensberg D, Baker A, Friedman L, Greene L, Huther M, Richardson D. JACC 17:17A,
1991.
56. Peters RW, Carliner NH: Overdrive atrial pacing for atrial flutter. PACE 14:683,
1991.
57. Peters RW, Zoble RG, Pawitan Y, Liebson P, Ettinger A: Relationship of onset of
myocardial infarction to the time of awakening. Circulation 84: (Suppl II) 244, 1991.
58. Greenberg HM, Hochman JS, Steinberg JS, Mitchell LB, Echt DS, Peters RW, Baker
AH, Greene HL, Dwyer E M Jr for the CAST Investigators. Interaction of ischemia and
encainide/flecainide treatment: A proposed mechanism for the increased mortality in
CAST I. Circulation 86:315, 1992.
59. Peters RW, Zoble RG, Brooks MM, Liebson PR, Barker A, Seals, MA for the CAST
Investigators: Increased onset of acute myocardial infarction on Monday. Circulation,
88:I-509, 1993.
60. Peters RW, Todd L, Brooks MM, Liebson PR, Wilhelmsen L for the CAST
Investigators. Smoking Cessation and Arrhythmic death: The CAST experience
Circulation . 88:I-556, 1993.
61. Riggio DW, Peters, RW, Gottlieb SS, Gold MR. Electrophysiologic effects of high
dose oral amiodarone load in heart failure patients. JACC 23:134A, 1994.
62. Foster M, Shorofsky SR, Peters RW, Gold MR. Combination therapy with type 1
antiarrhythmic drugs: electrophysiologic predictions of efficacy JACC 23:36A, 1994.
63. Gottlieb SS, Lauria S, Riggo DW. Peters RW, Shorofsky SR, Cines M, Froman D,
Gold MR. High dose oral amiodarone loading exerts important hemodynamic actions in
patients with congestive heart failure JACC 23:484A, 1994.
64. Florin, TJ; Weiss, DN; Feliciano, Z; Tummala, RV; Shorofsky, SR, Peters, RW, Gold
MR. Induction of atrial fibrillation with low energy shocks. Circulation . 1994;90:40I541.
65. Weiss, DN, Tummala R V, Feliciano Z, Peters, RW, Shorofsky SR, Froman, DM;
Gold, MR: A comparison of d-sotalol and d,l sotatol for treatment of ventricular
tachycardia circulation . Circulation 1994;90:40I-544
66. Peters, RW, McQuillan S, Kaye SA, Gold MR Increased Monday incidence of life
threatening Ventricular Arrhythmias: experience with a third generation implantable
defibrillator. JACC 1995;25:188A
67. Greene L, Peters R, McBride R, McAnulty J. Effects of intraventricular conduction
delay on survival in patients taking antiarrhythmic drugs. JACC 1995;25:19A.
68. Florin TJ, Weiss DN, Feliciano Z, Khalighi K, Schneider A, Shorofsky SR, Peters
RW, Gold MR. The induction of atrial fibrillation with low energy defibrillator shocks is
related to lead and pulse width. Circulation 1995;92:I-141.
69. Gold MR, Peters RW, Johnson J, Shorofsky SR. Complications associated with
subcutaneous and submuscular pectoral cardioverter defibrillator placement. PACE
1996;19:575.
70. Gold MR, Kavesh NG, Peters RW, Shorofsky SR. Biphasic waveforms prevent the
chronic rise of transvenous defibrillation thresholds. Circulation 1996;94:I-321.
71. Gold MR, Zhang X, Palmer G, Peters RW, Kavesh NG, Shorofsky SR. Clinical
predictors and efficacy of antitachycardia pacing therapy for the treatment of ventricular
tachycardia. PACE 1997;20:1567.
72. Degeratu FT, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in
implantable defibrillators J Am Coll Cardiol 1999;30:142A.
73. Page RL, Luceri RM, Gold MR, Peters RW, Follman DA, Russo AM, Powell JL,
Bigger JT, Kim CH, Sung RJ, Zipes DP, Yao Q, Lancaster S. Patterns of mortality in the
Antiarrhythmics versus Implantable Defibrillators (AVID) study registry: evidence for
increased mortality related to the winter holidays. PACE 1999;22:712.
74. Gold MR, Rottman JN, Wood MA, Lehmann MH, Batsford WP, Peters RW, Hafley
G, Buxton AE. The effect of clinical factors on the benefit of implantable defibrillators in
the MUSTT Trial. Circulation 1999;100:642. .
75, Peters RW, Gold MR, Carlson MD, Zipes DP, Follman D, Sheldon RS, Mounsey P,
Lancaster S and the AVID Investigators. Seasonal variation in implantable cardioverter
defibrillator therapy. J Am Coll Cardiol 2000;35:150A.
76. Gold MR, Daubert JP, Peters RW, Shorofsky SR. A clinical trial of a combined atrial
and ventricular defibrillator in patients without ventricular arrhythmias. J Am Coll
Cardiol 2000;35:115A.
77. Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk M, Peters RW, Gold MR.
Defibrillation thresholds improve significantly over time with an active pectoral lead
system. PACE 2000;23:631.
78. Kirby SR, Degeratu FT, Rashba EJ, Shorofsky SR, Peters RW, Gold MR. The
efficacy of multimodal therapy with pacing, cardioversion and amiodarone to maintain
sinus rhythm in patients with “chronic” atrial fibrillation and congestive heart failure. J
Am Coll Cardiol 2001;37:93A.
79. Rashba EJ, Macmurdy K, Cooklin M, Kirk M, Peters RW, Shorofsky SR, Gold MR.
Sympathetic blockade markedly reduces T wave alternans. Circulation 2001;104:II-690
80. Rashba EJ, Shorofsky SR, Peters RW, DeGroot PJ, Havel WJ, Gold MR. Low
capacitance shocks decrease the safety margin for transvenous ventricular defibrillation.
PACE 2002;25, 554.
81. Rashba EJ, Shorofsky SR, MacMurdy K, Peters RW, Sarang S, Gold MR. Prognostic
significance of indeterminate T wave alternans results. PACE 2002;25:564.
82. Rashba EJ, Shorofsky SR, MacMurdy K, Sarang S, Peters RW, Gold MR. Influence
of left ventricular function on the prognostic value of t wave alternans. PACE
2002;25:605.
83. Kirby DS, Shorofsky SR, Rashba EJ, Peters RW, Gold MR. The efficacy of
multimodal therapy for maintenance of sinus rhythm in patient swith “chronic” atrial
fibrillation and congestive heart failure. PACE 2002;25:600.
84. Koul A, Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Is 360 joules necessary for
biphasic transthoracic cardioversion of atrial fibrillation? PACE 2002;25:688.
85. Rashba EJ, Peters RW, Shorofsky SR, Gold MR. Enhanced detection of arrhythmia
vulnerability using T wave alternans and programmed ventricular stimulation. PACE
2002;25:563.
86. Dickfeld T, Lodge M, Voudoris A, Khan E, Ma C, Sayed S, Lee JH, Peters R,
Dilsizian V, Shorofsky S. Anatomic-metabolic scar imaging with positron emission
tomography for guidance of ventricular tachycardia ablations. Heart Rhythm Society,
2006.
BOOKS AND CHAPTERS:
1. Scheinman MM, Peters RW: Clinical and electropharmacologic characteristics of
patients with bundle branch block. In Cardiac Pacing. Edited by N. El - Sherif and P.
Samet. Grune and Stratton, New York, 1980.
2. Goldschlager N, Scheinman MM, and Peters RW: Atrioventricular intraventricular
block in patients with acute myocardial infarction. In Coronary Care. Edited by Karliner
JS and Gregoratos G. Churchill Livingston, New York, 1981, Chapter 18, pp 425-448.
3. Scheinman MM, Peters RW, Sauve MJ, Desai JM, Abbott JA: Clinical Significance of
HV interval in patients with chronic bundle branch block and the role of permanent
pacemaker insertion. In: Cardiac Electrophysiology Today, Academic Press, 1982.
4. Peters RW, Scheinman MM, Sauve MJ, Williams K, Desai J, Abbott J, Cogan J:
Bundle branch block: Anatomic electrophysiologic and clinical correlates. In
Cardiology Update. (Ed. E. Rapport), Elsevier, North Holland New York, 1983 pp 219240.
5. Morady F, Peters RW, Scheinman MM: Bradyarrhythmias and bundle branch block.
In Medical Emergencies (Ed. M. Scheinman), Saunders, Philadelphia, 1984, Chapter 7,
pp 135-151.
6. Peters RW, Scheinman MM: Anatomic and electrophysiologic aspects of fascicular
block. In Cardiac Arrhythmias: From Diagnosis to Therapy. (Ed M. Scheinman and
Samuel Levy), Futura, Mt. Kisco, New York, 1984, Chapter 7, pp 137-165.
7. Peters RW, Scheinman MM: Bundle branch block and atrioventricular conduction
disturbances. In Cardiology (Eds Parmley WW, Chatterjee K. JB Lippincott Company,
Philadelphia , 1988. Volume 1, Chapter 68 pp 1-22.
8. Peters RW, Scheinman MM: Bundle branch block and atrioventricular conduction
disturbances. In Cardiology: An Illustrated Text/Reference. (Eds. W.W. Parmley,
Chatterjee) JB Lippincott Company, Kansas City, 1991. Volume 1, Chapter 48 pp 111127.
9. Peters RW: Pacemaker techniques for managements of supraventricular tachycardia in
Cardiac Preexcitation Syndromes: Origins, evaluation and treatment. (Ed. D.C. Benditt,
D.W. Benson, Jr.) Kluwer Academic Publishers, Norwell, Massachusetts, 1986, Chapter
23, pp 481-490.
10. Peters RW: Heart Block in acute Myocardial Infarction. In Modern Coronary Care,
(Ed G. Francis and J. Alpert) Little, Brown and Company, Boston, 1995, Chapter 10, pp
177-192.
11. Peters RW: Effect of Beta-Blockers on Circadian Variation of Sudden Cardiac Death
In Survivors of Myocardial Infarction. In Beta-Blockers and Cardiac Arrhythmic (Ed. P.
Deedwania) Marcel Dekker, Inc., N.Y. 1992, Chapter 7, pp 151-164.
12. Ellenbogen KA, Peters RW: Indications for permanent and temporary cardiac pacing
In Principles of Cardiac Pacing (Ed K. Ellenbogen) Blackwell Scientific Publications,
Cambridge, MA 1996, 2nd Edition, Chapter 1, pp 1-36.
13. Gold MR, Peters RW: Tachycardias In Conn's Current Therapy (Ed R.E Rakel) WB
Saunders Company, Philadelphia, 1995 pp 236-241.
14. Peters, RW: Circadian rhythm of sudden cardiac death. In: Circadian Rhythms of
Cardiovascular Disorders (Ed P. Deedwania) Futura Publishing Company, Armonk,
N.Y. 1997, Chapter 8, pp147-162.
15. Gold MR, Peters, RW: Pacing in heart failure. In: Clinical Cardiac Pacing (Ed K
Ellenbogen, G Neal Kay, B Wilkoff) WB Saunders Company, Philadelphia, 2000,
Chapter 20, pp 497-507.
16. Peters RW, Gold MR. Bradyarrhythmias and indications for pacing – new and
emerging. In: Management of Cardiac Arrhythmias (Ed L Ganz) Humana Press, Totowa,
New Jersey 2002, Chapter 11, pp163-182.
17. Peters RW, Ellenbogen KA. Indications for permanent and temporary cardiac pacing.
In: Cardiac Pacing 3rd Edition (Ed K Ellenbogen) Blackwell Scientific Publications,
Cambridge, MA, 2001, Chapter 1 pp 1-47.
18. Gold MR, Peters RW. How great is the arrhythmic risk for heart failure patients and
does resynchronization therapy modify it. In: Cardiac Arrhythmias 2001 (Ed A Raviele),
Springer, Milan, Italy 2001, pp 151-156.
19. Peters RW, Gold MR. Permanent pacemakers and antiarrhythmic devices. In: Irwin
and Rippe’s Intensive Care Medicine, 5th Edition, Silverchair Science &
Communications, Charlottesville, VA. (In Press).
20. Gold MR, Peters RW. Newer applications of pacemakers. In: Cardiac
Electrophysiology: From Cell to Bedside. 4th Edition (Ed Zipes DP) W B Saunders,
Philadelphia. 2004, Chapter 110, pp1011-1017.
21. Peters RW, Gold MR. Heart Block. In: Conn’s Current Therapy 2005 (Eds Rakel RE,
Bopes ET) Elsevier Saunders 2005, pp 349-353.
22. Pugazhendhi P, Peters RW, Ellenbogen KA. Indications for permanent and temporary
cardiac pacing. In: Cardiac Pacing, 4th edition (Ed K Ellenbogen), Blackwell Scientific
Publications, Cambridge, MA 2005, chapter 1, pp 1-46.
23. Peters RW, Pugazhendhi, P, Ellenbogen KA. Indications for permanent and
temporary cardiac pacing. In Cardiac Pacing 5th edition (Ed K Ellenbogen), Blackwell
Scientific Publications, Cambridge, MA 2008, (In Press).
24. Peters RW, Gold MR. Newer applications of pacemakers. In: Cardiac
Electrophysiology: From Cell to Bedside. 5th Edition (Ed Zipes DP) WB Saunders,
Philadelphia (in Press).
EDUCATIONAL MATERIALS:
1. Audiovisual Tape Cassette Series on Acute Myocardial Infarction (National Library of
Medicine). Produced with funds granted from the National Medical Audiovisual Library,
Maryland 21201
a. Margaretten W. and Scheinman MM: Anatomy and pathology of acute myocardial
infarction.
b. Parmley W: Pathophysiology of acute myocardial infarction.
c. Peters RW and Goldman H: Diagnosis of acute myocardial infarction.
d. Scheinman MM: Arrhythmias in myocardial infarction.
e. Parmley W: Pump failure in myocardial infarction.